Pfeiffer Type 1

Disease Overview

Pfeiffer syndrome Type 1 is a rare genetic disorder characterized by premature fusion of certain skull bones (craniosynostosis), which affects the shape of the head and face. It is the mildest form of Pfeiffer syndrome, with relatively less severe complications compared to other types.

Disease Category

Genetic Disorder, Craniofacial Syndrome, Craniosynostosis Syndrome

Synonyms

Classic Pfeiffer Syndrome
Pfeiffer Syndrome Type 1
FGFR-Related Craniosynostosis

Signs & Symptoms

Craniosynostosis: premature fusion of the skull bones leading to an abnormal head shape
Midface hypoplasia: underdevelopment of the central part of the face
Broad and short thumbs and big toes (brachydactyly)
Partial soft tissue syndactyly: webbing or fusion of the skin between fingers and toes
Normal to mildly delayed cognitive development
Potential vision and hearing complications
Potential dental and orthodontic challenges
Characteristic facial features with widely spaced eyes

Causes

Pfeiffer syndrome Type 1 is caused by mutations in either the: - FGFR1 (Fibroblast Growth Factor Receptor 1) gene - FGFR2 (Fibroblast Growth Factor Receptor 2) gene

These genetic mutations affect: - Bone and tissue growth and development - Cell signaling during embryonic development - Typically inherited in an autosomal dominant pattern

Affected Populations

Prevalence: Approximately 1 in 100,000 births
Gender distribution: Affects males and females equally
No specific racial or ethnic predisposition

Disorders with Similar Symptoms

Apert Syndrome
Crouzon Syndrome
Saethre-Chotzen Syndrome
Jackson-Weiss Syndrome
Muenke Syndrome

Diagnosis

Diagnostic methods include: - Comprehensive clinical evaluation - Physical examination - Detailed family medical history - Radiographic imaging (CT scans, X-rays) - Genetic testing to identify FGFR1 or FGFR2 mutations - Prenatal genetic screening

Standard Therapies

Multidisciplinary medical team approach
Surgical intervention to correct cranial anomalies
Reconstructive surgery for midface hypoplasia and syndactyly
Continuous developmental monitoring
Physical and occupational therapy
Potential speech and hearing therapies
Psychological support for patient and family

Clinical Trials and Studies

Ongoing research at major craniofacial research centers
Genetic therapy investigations
Long-term developmental outcome studies
Surgical technique improvements

References

National Institutes of Health (NIH)
National Organization for Rare Disorders (NORD)
Genetic and Rare Diseases (GARD) Information Center
Orphanet
American Academy of Pediatrics
International Craniofacial Research Consortium

Programs & Resources

National Craniofacial Association (NCA)
March of Dimes Birth Defects Foundation
Children's Craniofacial Association (CCA)
Genetic counseling services
Online support groups and patient networks

Complete Report

Comprehensive medical evaluation and personalized treatment plans are essential. Consultation with genetic specialists, craniofacial surgeons, and multidisciplinary healthcare professionals is recommended for comprehensive management.

Pfieffer Type 1